Health Canada and FDA Move Towards A Request for Information Sharing (RIS) Program for Generic Drugs
On December 1, 2025, Health Canada announced the creation of a joint program with the U.S. Food and Drug Administration (FDA) to support the establishment of a Request for Information Sharing (RIS) program for generic drugs. Specific commitments and timelines under this program have not yet been released. The RIS program is intended to facilitate